Cintas Corporation (CTAS) Stock Forecast
Data as of Jul 31, 2026Industrials · Current price $205.03 (-0.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2026 | Andrew Wittmann | Robert W. Baird | $250.00 | +21.9% |
| Nov 25, 2025 | Jason Haas | Wells Fargo | $185.00 | -9.8% |
| Nov 11, 2025 | Oliver Davies | Redburn Partners | $184.00 | -10.3% |
| Dec 20, 2024 | Jason Haas | Wells Fargo | $184.00 | -10.3% |
| Dec 12, 2024 | Toni Kaplan | Morgan Stanley | $202.00 | -1.5% |
| Sep 26, 2024 | Joshua Chan | UBS | $240.00 | +17.1% |
| Sep 25, 2024 | George Tong | Goldman Sachs | $212.00 | +3.4% |
| Sep 25, 2024 | Ashish Sabadra | RBC Capital | $181.00 | -11.7% |
| Sep 24, 2024 | Manav Patnaik | Barclays | $210.00 | +2.4% |
| Sep 24, 2024 | Toni Kaplan | Morgan Stanley | $156.25 | -23.8% |
| Sep 24, 2024 | Jason Haas | Wells Fargo | $183.75 | -10.4% |
| Sep 17, 2024 | Jasper Bibb | Truist Financial | $225.00 | +9.7% |
| Sep 11, 2024 | Caydee Blankenship | CFRA | $170.00 | -17.1% |
| Aug 12, 2024 | Jason Haas | Wells Fargo | $183.75 | -10.4% |
| Aug 9, 2024 | Oliver Davies | Redburn Partners | $167.50 | -18.3% |
| Jul 19, 2024 | Shlomo Rosenbaum | Stifel Nicolaus | $199.50 | -2.7% |
| Jul 19, 2024 | Toni Kaplan | Morgan Stanley | $156.25 | -23.8% |
| Jul 19, 2024 | Jasper Bibb | Truist Financial | $212.50 | +3.6% |
| Jul 19, 2024 | Andrew Wittmann | Robert W. Baird | $193.75 | -5.5% |
| Mar 28, 2024 | Ashish Sabadra | RBC Capital | $181.25 | -11.6% |
Top Analysts Covering CTAS
CTAS vs Sector & Market
| Metric | CTAS | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.40 | 2.42 |
| Analyst Count | 9 | 8 | 19 |
| Target Upside | +12.2% | +109.1% | +18.0% |
| P/E Ratio | 43.26 | 36.61 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $2.89B | $2.93B | $2.97B | 8 |
| 2026-11-28 | $2.97B | $3.00B | $3.03B | 4 |
| 2027-02-28 | $3.00B | $3.03B | $3.06B | 4 |
| 2027-05-28 | $3.06B | $3.09B | $3.13B | 4 |
| 2027-05-31 | $11.94B | $12.07B | $12.15B | 15 |
| 2027-08-28 | $3.09B | $3.12B | $3.15B | 4 |
| 2027-11-28 | $3.16B | $3.19B | $3.23B | 4 |
| 2028-02-28 | $3.17B | $3.20B | $3.24B | 3 |
| 2028-05-28 | $3.26B | $3.29B | $3.32B | 3 |
| 2028-05-31 | $12.91B | $12.91B | $12.92B | 12 |
| 2029-05-31 | $13.58B | $13.73B | $13.80B | 7 |
| 2030-05-31 | $14.57B | $14.72B | $14.81B | 11 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $1.27 | $1.33 | $1.39 | 8 |
| 2026-11-28 | $1.34 | $1.36 | $1.38 | 3 |
| 2027-02-28 | $1.35 | $1.37 | $1.38 | 3 |
| 2027-05-28 | $1.37 | $1.38 | $1.40 | 3 |
| 2027-05-31 | $5.36 | $5.43 | $5.51 | 11 |
| 2027-08-28 | $1.43 | $1.45 | $1.47 | 3 |
| 2027-11-28 | $1.47 | $1.48 | $1.50 | 3 |
| 2028-02-28 | $1.44 | $1.46 | $1.48 | 4 |
| 2028-05-28 | $1.47 | $1.49 | $1.51 | 4 |
| 2028-05-31 | $5.67 | $6.02 | $6.30 | 7 |
| 2029-05-31 | $6.75 | $6.85 | $6.90 | 2 |
| 2030-05-31 | $7.88 | $7.99 | $8.05 | 5 |
Frequently Asked Questions
What is the analyst consensus for CTAS?
The consensus among 9 analysts covering Cintas Corporation (CTAS) is Hold with an average price target of $241.00.
What is the highest price target for CTAS?
The highest price target for CTAS is $250.00, set by Andrew Wittmann at Robert W. Baird on 2026-03-11.
What is the lowest price target for CTAS?
The lowest price target for CTAS is $22.63, set by Toni Kaplan at Morgan Stanley on 2022-07-15.
How many analysts cover CTAS?
9 analysts have issued ratings for Cintas Corporation in the past 12 months.
Is CTAS a buy or sell right now?
Based on 9 analyst ratings, CTAS has a consensus rating of Hold (2.67/5) with a +12.2% upside to the consensus target of $241.00.
What are the earnings estimates for CTAS?
Analysts estimate CTAS will report EPS of $1.33 for the period ending 2026-08-28, with revenue estimated at $2.93B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.